AVNS
Income statement / Annual
Last year (2025), Avanos Medical Inc's total revenue was $701.20 M,
an increase of 1.95% from the previous year.
In 2025, Avanos Medical Inc's net income was -$67.90 M.
See Avanos Medical Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$701.20 M |
$687.80 M |
$673.30 M |
$684.10 M |
$744.60 M |
$714.80 M |
$697.60 M |
$652.30 M |
$611.60 M |
$566.20 M |
| Cost of Revenue |
$352.20 M
|
$306.50 M
|
$293.60 M
|
$289.90 M
|
$364.70 M
|
$324.20 M
|
$295.40 M
|
$261.40 M
|
$274.70 M
|
$269.00 M
|
| Gross Profit |
$349.00 M
|
$381.30 M
|
$379.70 M
|
$394.20 M
|
$379.90 M
|
$390.60 M
|
$402.20 M
|
$390.90 M
|
$336.90 M
|
$297.20 M
|
| Gross Profit Ratio |
0.5
|
0.55
|
0.56
|
0.58
|
0.51
|
0.55
|
0.58
|
0.6
|
0.55
|
0.52
|
| Research and Development Expenses |
$23.10 M
|
$26.20 M
|
$27.20 M
|
$30.60 M
|
$32.30 M
|
$34.90 M
|
$37.70 M
|
$41.80 M
|
$38.20 M
|
$38.40 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$218.30 M
|
$315.10 M
|
$287.50 M
|
$323.10 M
|
$260.80 M
|
$284.80 M
|
$369.90 M
|
$314.20 M
|
$314.70 M
|
$328.20 M
|
| Other Expenses |
$169.20 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$410.60 M
|
$341.30 M
|
$314.70 M
|
$352.30 M
|
$293.10 M
|
$319.70 M
|
$407.60 M
|
$356.00 M
|
$352.90 M
|
$366.60 M
|
| Cost And Expenses |
$762.80 M
|
$647.80 M
|
$608.30 M
|
$642.20 M
|
$657.80 M
|
$643.90 M
|
$703.00 M
|
$617.40 M
|
$627.60 M
|
$635.60 M
|
| Interest Income |
$3.20 M
|
$5.10 M
|
$2.90 M
|
$1.20 M
|
$200.00 K
|
$1.20 M
|
$6.70 M
|
$7.80 M
|
$2.50 M
|
$600.00 K
|
| Interest Expense |
$4.00 M
|
$12.20 M
|
$15.00 M
|
$10.00 M
|
$3.30 M
|
$15.60 M
|
$15.00 M
|
$26.40 M
|
$31.60 M
|
$32.70 M
|
| Depreciation & Amortization |
$29.00 M
|
$45.50 M
|
$43.50 M
|
$41.10 M
|
$38.30 M
|
$42.90 M
|
$36.90 M
|
$33.50 M
|
$40.00 M
|
$41.00 M
|
| EBITDA |
-$33.20 M |
-$345.60 M |
$50.60 M |
$77.80 M |
$48.90 M |
-$2.00 M |
-$12.10 M |
$37.00 M |
-$600.00 K |
-$65.50 M |
| EBITDA Ratio |
-0.05
|
-0.5
|
0.08
|
0.11
|
0.07
|
-0
|
-0.02
|
0.06
|
-0
|
-0.12
|
| Operating Income Ratio |
-0.09
|
0.06
|
0.1
|
0.06
|
0.12
|
0.1
|
-0.01
|
0.05
|
-0.03
|
-0.12
|
| Total Other Income/Expenses Net |
-$4.60 M
|
-$443.30 M
|
-$72.90 M
|
-$15.20 M
|
-$79.50 M
|
-$131.40 M
|
-$58.60 M
|
-$53.00 M
|
-$56.20 M
|
-$69.80 M
|
| Income Before Tax |
-$66.20 M
|
-$403.30 M
|
-$7.90 M
|
$26.70 M
|
$7.30 M
|
-$60.50 M
|
-$64.00 M
|
-$18.10 M
|
-$72.20 M
|
-$139.20 M
|
| Income Before Tax Ratio |
-0.09
|
-0.59
|
-0.01
|
0.04
|
0.01
|
-0.08
|
-0.09
|
-0.03
|
-0.12
|
-0.25
|
| Income Tax Expense |
$1.70 M
|
-$17.00 M
|
$2.00 M
|
$5.20 M
|
$1.00 M
|
-$33.30 M
|
-$18.10 M
|
-$9.60 M
|
-$40.10 M
|
-$55.90 M
|
| Net Income |
-$67.90 M
|
-$392.10 M
|
-$61.80 M
|
$50.50 M
|
$6.30 M
|
-$27.20 M
|
-$45.90 M
|
$57.50 M
|
$79.30 M
|
$39.80 M
|
| Net Income Ratio |
-0.1
|
-0.57
|
-0.09
|
0.07
|
0.01
|
-0.04
|
-0.07
|
0.09
|
0.13
|
0.07
|
| EPS |
-1.46 |
-8.53 |
-1.33 |
1.08 |
0.13 |
-0.57 |
-0.96 |
1.22 |
1.69 |
0.85 |
| EPS Diluted |
-1.46 |
-8.53 |
-1.33 |
1.07 |
0.13 |
-0.57 |
-0.96 |
1.22 |
1.69 |
0.85 |
| Weighted Average Shares Out |
$46.40 M
|
$46.00 M
|
$46.60 M
|
$46.90 M
|
$48.10 M
|
$47.80 M
|
$47.60 M
|
$47.20 M
|
$46.52 M
|
$46.60 M
|
| Weighted Average Shares Out Diluted |
$46.40 M
|
$46.00 M
|
$46.60 M
|
$47.30 M
|
$48.60 M
|
$47.80 M
|
$47.60 M
|
$47.20 M
|
$46.80 M
|
$47.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
